Literature DB >> 21774995

Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis.

Shigeaki Suzuki1, Kimiaki Utsugisawa, Kazuo Iwasa, Takashi Satoh, Yuriko Nagane, Hiroaki Yoshikawa, Masataka Kuwana, Norihiro Suzuki.   

Abstract

Immune responses to ER stress have been closely related to the pathogenesis of autoimmune diseases. Using an immunoprecipitation assay, 24 (7.1%) of 336 MG serum samples immunoprecipitated a 90-kDa protein from the muscle cellular extracts, but none of the disease or healthy control sera. The 90-kDa protein was affinity-purified and found to match to ER chaperon GRP94 by matrix-assisted laser desorption/ionization-time of flight mass spectroscopy analysis. The frequency of associated autoimmune diseases was much higher in the anti-GRP94-positive than the -negative patients (71% versus 11%, p<0.001). Autoimmunity to ER chaperone GRP94 is associated with a subset of MG patients who have additional autoimmune diseases.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774995     DOI: 10.1016/j.jneuroim.2011.06.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

Review 1.  Different subsets of natural killer T cells may vary in their roles in health and disease.

Authors:  Vipin Kumar; Terry L Delovitch
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 2.  ER stress in skeletal muscle remodeling and myopathies.

Authors:  Dil Afroze; Ashok Kumar
Journal:  FEBS J       Date:  2017-12-29       Impact factor: 5.542

Review 3.  Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease.

Authors:  Kyle R Bohnert; Joseph D McMillan; Ashok Kumar
Journal:  J Cell Physiol       Date:  2017-05-16       Impact factor: 6.384

4.  Association of HSP90B1 genetic polymorphisms with efficacy of glucocorticoids and improvement of HRQoL in systemic lupus erythematosus patients from Anhui Province.

Authors:  Xiu-Xiu Sun; Su-Su Li; Man Zhang; Qiao-Mei Xie; Jian-Hua Xu; Sheng-Xiu Liu; Yuan-Yuan Gu; Fa-Ming Pan; Jin-Hui Tao; Sheng-Qian Xu; Shuang Liu; Jing Cai; De-Guang Wang; Long Qian; Chun-Huai Wang; Li Lian; Hui Xiao; Pei-Ling Chen; Chun-Mei Liang; You-Bing Fang; Qiang Zhou; Hai-Liang Huang; Hong Su; Hai-Feng Pan; Dong-Qing Ye; Yan-Feng Zou
Journal:  Am J Clin Exp Immunol       Date:  2018-04-05

5.  NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation.

Authors:  Rachael Viale; Randle Ware; Igor Maricic; Varun Chaturvedi; Vipin Kumar
Journal:  Curr Immunol Rev       Date:  2012-11-01

6.  A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts.

Authors:  Kerrie Vaughan; Yohan Kim; Alessandro Sette
Journal:  Autoimmune Dis       Date:  2012-12-02

Review 7.  Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity.

Authors:  Valerie R Wiersma; Marek Michalak; Trefa M Abdullah; Edwin Bremer; Paul Eggleton
Journal:  Front Oncol       Date:  2015-01-29       Impact factor: 6.244

8.  Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.

Authors:  Yurika Watanabe; Shigeaki Suzuki; Hiroaki Nishimura; Ken-Ya Murata; Takashi Kurashige; Masamichi Ikawa; Masaru Asahi; Hirofumi Konishi; Satsuki Mitsuma; Satoshi Kawabata; Norihiro Suzuki; Ichizo Nishino
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

9.  ER Stress Proteins in Autoimmune and Inflammatory Diseases.

Authors:  Daisuke Morito; Kazuhiro Nagata
Journal:  Front Immunol       Date:  2012-03-15       Impact factor: 7.561

10.  A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.